Pfizer Inc (PFE) and BioNTech SE (BNTX) have agreed to provide the US government with 100 million doses of their COVID-19 vaccine candidate BNT162, after Pfizer successfully manufactures and obtains approval or emergency use authorization from the US Food and Drug Administration (FDA).The U.S. government will pay the companies $1.95 billion upon the receipt of the first 100 million doses, following FDA authorization or approval. The U.S. government also can acquire up to an additional 500 million doses.Shares in Pfizer are up 5% in Wednesday’s pre-market trading while BioNTech is up 6%.“Expanding Operation Warp Speed’s diverse portfolio by adding a …read more
Source:: Yahoo Finance
